| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |